NEO/SAN (NEO/SAN)

Cboe Canada: NEO/SAN · CAD

CA$9.58

+0.04 (+0.4%)· Recorded snapshot

Market cap	145B
Revenue (ttm)	79.4B
Net income (ttm)	6.4B
EPS (ttm)	CA$0.41
P/E (trailing)	23.1x
P/E (forward)	8.6x
Dividend	CA$0.83 (8.67%)
Volume	137
Beta	0.28

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 79.4B
Net income (ttm): 6.4B
EPS (ttm): CA$0.41
P/E (trailing): 23.1x
P/E (forward): 8.6x
Market cap: 145B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E8.6

P25 n/aP50 n/aP75 n/a

Trailing P/E23.1

P25 n/aP50 n/aP75 n/a

ROE5.7

P25 n/aP50 n/aP75 n/a

ROIC9.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NEO/SAN indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

EUR

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	France
Country code	CA
Earnings date	2026-10-30
Employees	74,846
Employees change	-8,032
Employees growth	-9.69%
Enterprise value	CAD 172.5B
Exchange	Cboe Canada
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1994
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CA80106A1021
Last earnings date	2026-07-30
Last refreshed	2026-10-29
Market cap	CAD 145B
Next earnings date	2026-10-30
Price	CAD 9.58
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	neo/SAN
Website	https://www.sanofi.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	18.52x
Average P/E ratio (3Y)	18.87x
Average P/E ratio (5Y)	17.73x
Earnings yield	4.32%
EV/Earnings	26.32x
EV/EBIT	10.69x
EV/EBITDA	7.96x
EV/FCF	10.38x
EV/Sales	2.21x
FCF / EV yield	9.64%
FCF yield	11.51%
Forward P/E	8.56x
Graham number	8.64449
Graham upside	-9.77%
Lynch fair value	CAD 2.17
Lynch upside	-77.31%
P/(FCF - SBC) ratio	8.98x
P/(OCF - SBC) ratio	7.58x
P/B ratio	1.25x
P/E ratio	23.14x
P/FCF ratio	8.69x
P/OCF ratio	7.37x
P/S ratio	1.78x
Price / tangible book value	9.78x
Price/EBITDA ratio	6.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.16%
EBITDA margin	27.68%
Effective tax rate	23.16%
FCF margin	21.36%
Gross margin	73.45%
Operating margin	21.16%
Pretax margin	10.62%
Profit margin	8.09%
Profit per employee	CAD 85,796
Profitable quarters	2
Profitable years	21
Revenue per employee	CAD 1.1M
ROA	5.09%
ROA (5Y)	4.55%
ROCE	10.66%
ROE	5.71%
ROE (5Y)	8.3%
ROIC	9.12%
ROIC (5Y)	8.98%
SBC / revenue	0.67%
Tax / revenue	2.46%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-55.57%
EPS growth (Q)	-91.2%
EPS growth (QoQ)	-78.75%
EPS growth 10Y	0.16%
EPS growth 3Y	-21.9%
EPS growth 5Y	-6.58%
EPS growth years	2
FCF growth	5.47%
FCF growth (Q)	236.79%
FCF growth (QoQ)	23.47%
FCF growth 3Y	5.42%
FCF growth 5Y	8.11%
Gross profit growth	10.15%
Gross profit growth (Q)	21.54%
Gross profit growth 3Y	3.79%
Gross profit growth 5Y	7.18%
Net income growth	-56.63%
Net income growth (Q)	-91.29%
Net income growth (QoQ)	-78.75%
Net income growth 3Y	-22.84%
Net income growth 5Y	-7.28%
Net income growth years	2
OCF growth	5.56%
OCF growth (Q)	102.46%
OCF growth (QoQ)	75.88%
OCF growth 10Y	3.84%
OCF growth 3Y	4.87%
OCF growth 5Y	7.57%
Operating income growth	10.31%
Operating income growth (Q)	51.11%
Operating income growth 3Y	-1.98%
Operating income growth 5Y	5.14%
Revenue growth	6.96%
Revenue growth (Q)	14.58%
Revenue growth (QoQ)	9.39%
Revenue growth 10Y	3.67%
Revenue growth 3Y	2.04%
Revenue growth 5Y	5.43%
Revenue growth quarters	3
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -2.9B
Depreciation and amortization	CAD 5B
EBIT	CAD 16.8B
EBITDA	CAD 22B
EPS	CAD 0.41
Financing cash flow	CAD -11.4B
Free cash flow	CAD 16.3B
Free cash flow minus SBC	CAD 15.8B
Gross profit	CAD 58.3B
Income taxes	CAD 2B
Investing cash flow	CAD -22.4B
Net borrowing	CAD -344.4M
Net cash flow	CAD -14.6B
Net income	CAD 6.4B
Operating cash flow minus SBC	CAD 18.7B
Operating income	CAD 16.8B
Revenue	CAD 79.4B
Stock-based compensation	CAD 528.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD 93.72
Debt / EBITDA	1.71
Debt / equity	0.34
Debt / FCF	2.35
Goodwill	CAD 65.4B
Interest coverage	17.08
Long-term assets	CAD 160.3B
Long-term liabilities	CAD 46.8B
Net cash (debt)	CAD -27.9B
Net cash / market cap	-19.75%
Net debt / EBITDA	1.27
Net debt / equity	0.25
Net debt / FCF	1.72
Piotroski F-Score	6
Property, plant and equipment	CAD 18.6B
Shareholders' equity	CAD 112.9B
Tangible book value	CAD 14.5B
Tangible book value per share	CAD 12.08
Total assets	CAD 209.4B
Total cash	CAD 10.3B
Total debt	CAD 38.3B
Total liabilities	CAD 96.5B
WACC	4.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.39
Current assets	CAD 49.1B
Current liabilities	CAD 49.8B
Current ratio	0.99
Inventory turnover	1.25
Net working capital	CAD 803.1M
Quick ratio	0.49
Working capital	CAD -661.9M
Working capital turnover	21.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.54%
Dividend growth	0%
Dividend growth years	0
Dividend payment years	1
Dividend per share	CAD 0.83
Dividend yield	8.67%
Ex-dividend date	2026-05-06
Last dividend	CAD 0.53
Payout ratio	124.38%
Shareholder yield	11.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 9.73
1D price change	0.42%
1M price change	4.36%
1M total return	4.36%
1W price change	4.7%
1W total return	4.7%
1Y price change	-13.46%
1Y return CAGR	-13.47%
1Y total return	-13.46%
20-day SMA	CAD 9.25
200-day SMA	CAD 9.84
3M price change	-1.44%
3M total return	-1.44%
50-day SMA	CAD 9.56
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 11.60
52-week high date	2025-11-18
52-week low	CAD 9.15
52-week low date	2026-10-21
6M price change	-8.06%
6M total return	-8.06%
All-time high	CAD 11.60
All-time high date	2025-11-17
All-time low	CAD 9.15
All-time low date	2026-10-16
Average true range (ATR)	CAD 0.06
Average volume	50.5
Beta (5Y)	0.28
Change from 52-week high	-17.41%
Change from 52-week low	4.7%
Change from all-time high	-17.41%
Change from all-time low	4.7%
Change from open	2.46%
Day's gap	-1.99%
Dollar volume	CAD 1,312
High price	CAD 9.58
Low price	CAD 9.35
Monthly RSI	0
Open price	CAD 9.35
Position in 52-week range	100%
Previous close	CAD 9.54
Price vs 150-day SMA	-1.55%
Price vs 20-day SMA	3.59%
Price vs 200-day SMA	-2.65%
Price vs 50-day SMA	0.19%
Relative volume	2.72
RSI	70.16
Sharpe ratio	-0.71
Sortino ratio	-0.69
Volume	137
Weekly RSI	49.08
YTD price change	-9.37%
YTD total return	-9.37%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.1B
Shares change (QoQ)	-0.63%
Shares change (YoY)	-2.54%
Shares held by insiders	0.02%
Shares held by institutions	43.06%

Deeper analysis on NEO/SAN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NEO/SAN report

Is a complete NEO/SAN research report available?

No complete published report is available for neo/SAN (NEO/SAN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NEO/SAN (NEO/SAN)

Price

Financial snapshot

Fair-value bridge

Latest news · NEO/SAN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NEO/SAN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NEO/SAN

Frequently asked questions